New device created to 'better identify and tackle cancerous cells'

23 February 2012

An innovative microfluidic device being developed in the US could advance cancer diagnosis and treatment.

Sukant Mittal and colleagues from the Massachusetts Institute of Technology are the minds behind the new gadget, which is able to isolate dangerous target cells at a quicker rate than current technology.

As such, medical professionals could soon be able to search for signs of tumour cells, stem cells or fetal cells in a body more efficiently in the near future.

Mr Mittal believes the device has the means to advance the medical industry, seeing as though the designs of current gadgets mean that physicians are "basically looking for a needle in a haystack".

Mehmet Toner, a professor of biomedical engineering, has also worked on the device, and commented: "This novel approach may enable exciting diagnostic and therapeutic opportunities that are not feasible using existing technologies."

Researchers at Cardiff University and King's College London have conducted their own study, which highlights that zinc can play a pivotal part in combating the cells which lead to the development of aggressive breast cancer.

Posted by Edward Bartel


Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.
 

Find a treatment, test or scan available at:

or

Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.

or

Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...

Categories

Cancer

© Spire Healthcare Group plc (2016)